Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ASS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
COX14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VAMP8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST2H2AA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST3H2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CIR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCAND1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC52A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM174B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COX4I1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC12B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM120B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C4orf3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STAT6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on